166 related articles for article (PubMed ID: 30658988)
1. Estimation of impact of
Lloyd A; Piglowska N; Ciulla T; Pitluck S; Johnson S; Buessing M; O'Connell T
Br J Ophthalmol; 2019 Nov; 103(11):1610-1614. PubMed ID: 30658988
[TBL] [Abstract][Full Text] [Related]
2. Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease.
Zimmermann M; Lubinga SJ; Banken R; Rind D; Cramer G; Synnott PG; Chapman RH; Khan S; Carlson J
Value Health; 2019 Feb; 22(2):161-167. PubMed ID: 30711060
[TBL] [Abstract][Full Text] [Related]
3. Voretigene neparvovec-rzyl for treatment of
Ciulla TA; Hussain RM; Berrocal AM; Nagiel A
Expert Opin Biol Ther; 2020 Jun; 20(6):565-578. PubMed ID: 32149547
[No Abstract] [Full Text] [Related]
4. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
[TBL] [Abstract][Full Text] [Related]
5. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.
Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
Patient; 2019 Aug; 12(4):383-392. PubMed ID: 30607809
[TBL] [Abstract][Full Text] [Related]
6. Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints.
Grutters JP; Joore MA; van der Horst F; Verschuure H; Dreschler WA; Anteunis LJ
Qual Life Res; 2007 Oct; 16(8):1439-49. PubMed ID: 17647093
[TBL] [Abstract][Full Text] [Related]
7. Shared decision-making, control preferences and psychological well-being in patients with RPE65 deficiency awaiting experimental gene therapy.
Nelles M; Stieger K; Preising MN; Kruse J; Lorenz B
Ophthalmic Res; 2015; 54(2):96-102. PubMed ID: 26278420
[TBL] [Abstract][Full Text] [Related]
8. Interpreting parental proxy reports of (health-related) quality of life for children with unilateral cochlear implants.
Sach TH; Barton GR
Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):435-45. PubMed ID: 17161471
[TBL] [Abstract][Full Text] [Related]
9. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
10. Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities Index.
Pickard AS; Johnson JA; Feeny DH; Shuaib A; Carriere KC; Nasser AM
Stroke; 2004 Feb; 35(2):607-12. PubMed ID: 14726549
[TBL] [Abstract][Full Text] [Related]
11. The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene.
Chung DC; Bertelsen M; Lorenz B; Pennesi ME; Leroy BP; Hamel CP; Pierce E; Sallum J; Larsen M; Stieger K; Preising M; Weleber R; Yang P; Place E; Liu E; Schaefer G; DiStefano-Pappas J; Elci OU; McCague S; Wellman JA; High KA; Reape KZ
Am J Ophthalmol; 2019 Mar; 199():58-70. PubMed ID: 30268864
[TBL] [Abstract][Full Text] [Related]
12. Technological advancements to study cellular signaling pathways in inherited retinal degenerative diseases.
Roy A; Hilhorst R; Groten J; Paquet-Durand F; Tomar T
Curr Opin Pharmacol; 2021 Oct; 60():102-110. PubMed ID: 34388439
[TBL] [Abstract][Full Text] [Related]
13. RPE65 Mutation-associated Inherited Retinal Disease and Gene Therapies.
Camp DA; Falabella P; Ciulla TA
Int Ophthalmol Clin; 2021 Oct; 61(4):125-132. PubMed ID: 34584049
[No Abstract] [Full Text] [Related]
14. An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care.
Easton T; Milte R; Crotty M; Ratcliffe J
Qual Life Res; 2018 May; 27(5):1283-1294. PubMed ID: 29305782
[TBL] [Abstract][Full Text] [Related]
15. Extent of Exacerbation of Chronic Health Conditions by Visual Impairment in Terms of Health-Related Quality of Life.
Park SJ; Ahn S; Woo SJ; Park KH
JAMA Ophthalmol; 2015 Nov; 133(11):1267-75. PubMed ID: 26379209
[TBL] [Abstract][Full Text] [Related]
16. Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis.
Hussain RM; Tran KD; Maguire AM; Berrocal AM
Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):661-663. PubMed ID: 31671202
[TBL] [Abstract][Full Text] [Related]
17. Development of Methods for the Mapping of Utilities Using Mixture Models: Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with Asthma.
Gray LA; Hernández Alava M; Wailoo AJ
Value Health; 2018 Jun; 21(6):748-757. PubMed ID: 29909881
[TBL] [Abstract][Full Text] [Related]
18. Spatially Resolved Spectral Sensitivities as a Potential Read-out Parameter in Clinical Gene Therapeutic Trials.
Lorenz B; Wegscheider E; Hamel C; Preising MN; Stieger K
Ophthalmic Res; 2017; 58(4):194-202. PubMed ID: 28697496
[TBL] [Abstract][Full Text] [Related]
19. LONGITUDINAL STUDY OF RPE65-ASSOCIATED INHERITED RETINAL DEGENERATIONS.
Pierrache LHM; Ghafaryasl B; Khan MI; Yzer S; van Genderen MM; Schuil J; Boonstra FN; Pott JWR; de Faber JTHN; Tjon-Fo-Sang MJH; Vermeer KA; Cremers FPM; Klaver CCW; van den Born LI
Retina; 2020 Sep; 40(9):1812-1828. PubMed ID: 32032261
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
